Quiñ ones, Henry, Roberto Collazo, and Orson W. Moe. The dopamine precursor L-dihydroxyphenylalanine is transported by the amino acid transporters rBAT and LAT2 in renal cortex. Am J Physiol Renal Physiol 287: F74 -F80, 2004; 10.1152/ajprenal.00237.2003.-The intrarenal autocrine-paracrine dopamine (DA) system is critical for Na ϩ homeostasis. L-Dihydroxyphenylalanine (L-DOPA) uptake from the glomerular filtrate and plasma provides the substrate for DA generation by the renal proximal tubule. The transporter(s) responsible for proximal tubule L-DOPA uptake has not been characterized. Renal cortical poly-A ϩ RNA injected into Xenopus laevis oocytes induced L-DOPA uptake in a time-and dose-dependent fashion with biphasic K ms in the millimolar and micromolar range and independent of inward Na ϩ , K ϩ , or H ϩ gradients, suggesting the presence of lowand high-affinity L-DOPA carriers. Complementary RNA from two amino acid transporters yielded L-DOPA uptake significantly above water-injected controls the rBAT/b 0,ϩ AT dimer (rBAT) and the LAT2/4F2 dimer (LAT2). In contradistinction to renal cortical poly-A ϩ , L-DOPA kinetics of rBAT and LAT2 showed classic MichaelisMenton kinetics with K ms in the micromolar and millimolar range, respectively. Sequence-specific antisense oligonucleotides to rBAT or LAT2 (AS) caused inhibition of rBAT and LAT2 cRNA-induced L-DOPA transport and cortical poly-A ϩ -induced arginine and phenylalanine transport. However, the same ASs only partially blocked poly-A ϩ -induced L-DOPA transport. In cultured kidney cells, silencing inhibitory RNA (siRNA) to rBAT significantly inhibited L-DOPA uptake. We conclude that rBAT and LAT2 can mediate apical and basolateral L-DOPA uptake into the proximal tubule, respectively. Additional L-DOPA transport mechanisms exist in the renal cortex that remain to be identified. sodium balance; amino acid transport; proximal tubule THE INTRARENAL AUTOCRINE-PARACRINE dopamine (DA) system is an important mediator of natriuresis in mammalian Na ϩ homeostasis. There is strong evidence that urinary DA is primarily generated in the kidney and not derived from the plasma or from dopaminergic neurons innervating the renal parenchyma (31). Because the kidney lacks the ability to hydroxylate tyrosine, the starting substrate in the renal DA synthetic pathway is L-dihydroxyphenylalanine (L-DOPA). L-DOPA is taken up by the renal proximal tubule (32, 38) and decarboxylated into DA by aromatic amino acid decarboxylase (34). The proximal tubule (PT) seems to possess most of the decarboxylase activity and is the principal site of DA synthesis in the kidney (13, 14) . In contrast to the origin of renal DA synthesis, the site of DA action in the kidney is far from unique. All five isoforms of the DA receptors are found in the kidney and are distributed extensively in the vasculature and the renal epithelia (5). In the kidney, DA can regulate renal plasma flow (20), glomerular filtration (20), tubuloglomerular feedback (14), renin release (1, 2), and epithelial ion and water transport (22, 35) .
sodium balance; amino acid transport; proximal tubule THE INTRARENAL AUTOCRINE-PARACRINE dopamine (DA) system is an important mediator of natriuresis in mammalian Na ϩ homeostasis. There is strong evidence that urinary DA is primarily generated in the kidney and not derived from the plasma or from dopaminergic neurons innervating the renal parenchyma (31) . Because the kidney lacks the ability to hydroxylate tyrosine, the starting substrate in the renal DA synthetic pathway is L-dihydroxyphenylalanine (L-DOPA). L-DOPA is taken up by the renal proximal tubule (32, 38) and decarboxylated into DA by aromatic amino acid decarboxylase (34) . The proximal tubule (PT) seems to possess most of the decarboxylase activity and is the principal site of DA synthesis in the kidney (13, 14) . In contrast to the origin of renal DA synthesis, the site of DA action in the kidney is far from unique. All five isoforms of the DA receptors are found in the kidney and are distributed extensively in the vasculature and the renal epithelia (5) . In the kidney, DA can regulate renal plasma flow (20) , glomerular filtration (20) , tubuloglomerular feedback (14) , renin release (1, 2) , and epithelial ion and water transport (22, 35) .
Considering the plethora of actions of DA in the kidney, the understanding of its synthesis assumes paramount importance. DA synthesis in the PT is regulated by acute as well as chronic changes in extracellular fluid volume induced by saline infusion (18) and increased dietary salt intake (8, 21) , respectively. The mechanism by which the intrarenal DA system senses and reacts to changes in effective extracellular fluid volume is poorly understood. The current data indicate that there is interplay between the DA system and other intrarenal paracrine networks such as the local renin-angiotensin (2) and adenosine systems (36) . In addition, the decarboxylation of L-DOPA to DA appears to be modulated by changes in dietary salt (27, 30) . To fully understand the regulation of DA genesis by the PT, one needs to commence at the very first step, the uptake of L-DOPA into the PT.
Baines and Chan (3) showed that when L-[ 3 H]DOPA was infused either from the peritubular or luminal side of the proximal tubule, a significant percentage of the injected L-[ 3 H]-DOPA was converted into DA and excreted in the urine (3). The process was intact in the denervated kidney, suggesting that this was not a neurogenic mechanism. L-DOPA uptake by the proximal tubule has been characterized in one study using micropuncture by Chan showing L-DOPA uptake by the PT cell to be carrier mediated, stereospecific, energy dependent, pH independent, and competitively inhibited by L-phenylalanine (4) . There are also studies addressing L-DOPA uptake using renal cortical slices (32) as well as cultured renal cell lines (9, 34) . From this body of literature, one or more models have been constructed depicting a carrier-mediated process of L-DOPA uptake in both the apical and basolateral membranes. However, the actual identities of the L-DOPA transporters remain elusive. In recent years, a large number of complementary DNAs from the proximal tubule have been identified to mediate various amino acid transport processes when expressed in heterologous systems (37) . In this study, we examined several candidate amino acid transporters for their ability to take L-DOPA as a substrate in Xenopus laevis oocytes and compared their characteristics to poly-A ϩ RNA from the renal cortex. We conclude that L-DOPA uptake into the PT is mediated by apical rBAT and basolateral LAT2. Other yet unidentified transporters also participate in L-DOPA uptake.
EXPERIMENTAL PROCEDURES
RNA preparation. Native RNA from rat renal cortex was isolated by homogenizing dissected renal cortex in GTC [in M: 4 guanidium thiocyanate, 0.1 2-mercaptoethanol, 0.025 Na 3 citrate (pH 7.0), wt/vol 0.5% N-lauroyl-sarcosine, and RNA was phenol/chloroform-extracted and ethanol-precipitated. Poly-A ϩ RNA was isolated by oligo-dT affinity chromatography and size-fractionated by a continuous sucrose density gradient (6 -20% wt/vol). The range of kilobases recovered from each fraction was confirmed by formaldehyde gel electrophoresis with RNA ladder. Complementary RNAs (5Ј-methyl-capped) were transcribed in vitro from linearized cDNA by in vitro transcription kit. Plasmids containing the sequence for rBAT and LAT2, respectively, were linearized by restriction enzyme cut and cRNA synthesized using T7 and SP6 RNA polymerases, respectively. Integrity and size of cRNAs were confirmed by ethidium bromide gel electrophoresis. 3 H]DOPA) for the specified time at 20°C. Isotope uptake was stopped by washing the oocytes with the rinse solution supplemented with 5 mM L-DOPA at 4°C. Individual oocytes were dissolved in 10% SDS and radioactivity was determined by scintillation counting. For dose-related isotope uptake, oocytes were injected with either 5, 10, 20, and 40 ng of renal cortical poly-A ϩ 3 days before the uptake assay. For cation dependence, choline was substituted isoosmotically in the uptake solution by Na ϩ or K ϩ , and pH was adjusted to either 7.4 or 5.4. In experiments examining trans-activation of LAT2 by phenylalanine, oocytes were injected with 1 nmol of L-phenylalanine 6 h before isotope uptake. For kinetic experiments, separate groups of oocytes were incubated in uptake solution containing varying concentrations of unlabeled L-DOPA (0.01, 0.05, 0.100, 0.200, 0.250, 0.500, 1.00, and 2.0 mM) for 15 min for flux calculation. Michaelis-Menton kinetics were analyzed by Eadie-Hofstee transformation (Sigmaplot, Rockware, Golden, CO) to approximate K m and Vmax. Antisense oligonucleotides were synthesized to be complementary to the first 21-29 coding nucleotides of rBAT and LAT2 and annealed to the RNA (55°C ϫ 10 min and then 4°C ϫ 20 min) to block translation (5Ј-GTCCTCAT-TCATGTCTATCCG-3Ј for rat rBAT, 5Ј-GGTTCCCTTTTC-CATCTTTCTCCGTAGGG-3Ј for rat LAT2). Separate groups of oocytes were injected with either renal cortical poly-A ϩ , rBAT cRNA, and LAT2 cRNA with or without 15 ϫ molar excess of AS for rBAT or AS for LAT2 followed by isotope uptake determination.
Silencing inhibitory RNA experiment. Silencing inhibitory RNA target sites were chosen by scanning the OKP rBAT mRNA sequence for AA dinucleotides, recording the 19 nucleotides immediately downstream of the AA, and then comparing the potential siRNA target sequences with an appropriate genome database to eliminate any sequences with significant homology to other genes. After selecting the OKP rBAT siRNA target site, a DNA oligonucleotide consisting of a 19-nucleotide sense siRNA sequence linked to its antisense complementary siRNA sequence by a short spacer (TTCAA-GAGA) was designed. Nucleotide overhangs to the BamHI and HindIII restriction sites were added to the 5Ј-and 3Ј-end of the oligonucleotides to be cloned into pSilencer 2.0 or 3.0. Two different siRNAs were designed and named siRNA 20 and siRNA 54. After being cloned, the plasmid containing the oligonucleotide sequence for OKP rBAT siRNA was transfected into OKP cells in culture following the Lipofectamine Plus procedure from Invitrogen using cells plated in six-well plates. Seventy to eighty percent of tranfection efficiency was documented in GFP gene containing mammalian cell expression vector-transfected OKP cells by immunofluorescence microscopy quantification before L-DOPA uptake studies were performed.
L-DOPA uptake in mammalian culture cells. L-DOPA uptake was initiated by the addition of 1 ml of Hanks' medium (137 mM NaCl, 5 mM KCl, 0.8 mM MgSO 4, 0.33 mM Na2HPO4, 0.44 mM KH2PO4, 0.25 mM CaCl2, 1.0 mM MgCl2, 0.15 mM Tris⅐HCl, 1.0 mM sodium butyrate, pH 7.4) with 4.7 Ci of 3 H-L-DOPA and 100 M unlabeled L-DOPA. Cells were incubated at room temperature for 15 min. Uptake was terminated by rapid removal of uptake solution by means of vacuum pump connected to a Pasteur pipette followed by two washes with ice-cold Hanks' medium containing 5 mM unlabeled L-DOPA. Five-hundred microliters of 4% SDS were added to each well of cells for lysis. Twenty microliters of aliquot were used for protein concentration determination. The rest was used for determination of L-[
3 H]DOPA in scintillation counter. Final uptake for each sample was expressed in counts per minute per milligram of protein per 15 minutes.
RESULTS

Rat renal cortical poly-A
ϩ RNA induces L-DOPA uptake in X. laevis oocytes. Renal cortical poly-A ϩ RNA induced timeand concentration-dependent L-DOPA uptake in oocytes (Fig.  1, A and B, respectively) . Oocytes injected with water and no poly-A ϩ RNA were associated with L-DOPA transport that was always substracted in later L-DOPA uptake experiments. L-DOPA transport was independent of Na ϩ , K ϩ , or pH gradients (data not shown). This indicated that there are RNA sequences in the renal cortex coding for an L-DOPA carrier. Injection of size-fractionated renal cortical poly-A ϩ RNA showed a single peak residing in the fractions corresponding to the transcript in the 2-to 4-kb range (Fig. 2) , which encompasses most of the amino acid transporters. Analysis of substrate kinetics showed a complex pattern (Fig. 3A) , and a linear transformation of the data (Fig. 3B ) yielded two K m s corresponding to a high-affinity (10 -25 M) and a low-affinity (ϳ1 mM) component, suggesting that there is more than one L-DOPA transporter in the renal cortex. Given the structural similarity between L-DOPA and phenylalanine and previous data showing competitive inhibition of the L-DOPA transport in the proximal tubule by L-phenylalanine (4), we screened three cloned amino acid transporters as putative candidates for L-DOPA transporters.
Oocytes injected with rBAT cRNA showed sevenfold higher L-DOPA uptake than the water-injected controls (see Fig. 5 ). Coinjection of rBAT and the subunit b 0,ϩ AT further induces L-DOPA uptake to about ninefold of that of water. Arginine uptake was used as a positve control for rBAT (Fig. 4) . This is not an unexpected finding as oocytes express an endogenous homolog of b 0,ϩ AT (11). Similar to cortical poly-A ϩ RNA, the rBAT-induced L-DOPA uptake is also independent of inwardly directed Na ϩ , K ϩ , and pH gradients (Fig. 5 ). This suggests that rBAT induces expression of an L-DOPA carrier with functional similarities to the one in renal cortical poly-A ϩ RNA. To further examine whether the rBAT sequence accounts for the L-DOPA uptake induced by renal cortical poly-A ϩ RNA, we compared the substrate kinetics of rBAT-induced L-DOPA uptake to that of renal cortical poly-A ϩ RNA-induced L-DOPA uptake (Figs. 3 and 6) . Although renal cortical poly-A ϩ RNAinduced uptake can be resolved into two components with two K m s (10 -25 M and ϳ1 mM), rBAT cRNA shows classic Michaelis-Menton kinetics with a single K m of ϳ25 M (Fig.  6) . It is possible that the high-affinity L-DOPA transporter in renal cortical poly-A ϩ RNA is rBAT. We used a second approach to delineate this fact. We reduced rBAT contribution to poly-A ϩ -induced L-DOPA transport by blocking rBAT translation with rBAT-specific antisense oligonucleotides. Antisense oligonucleotides in proximity of the start codon were annealed with rBAT cRNA or rat renal cortical poly-A ϩ RNA, injected into oocytes, and the effect on L-DOPA uptake was assessed (Fig. 7) . Antisense oligonucleotide rBAT blocks ϳ30% of the L-DOPA uptake induced by poly-A ϩ RNA and ϳ80% of the L-DOPA or L-arginine transport induced by rBAT cRNA. Sense or scrambled oligonucleotides had no effect on L-DOPA transport (not shown).
Oocytes injected with LAT2/4F2 cRNA showed a twofold higher L-DOPA uptake than water-injected oocytes (Fig. 8) . In this case, both subunits were coinjected for all the experiments because none of the subunits are expressed in the oocytes. Because LAT2/4F2 can sustain amino acid countertransport, we examined whether trans phenylalanine can stimulate L-DOPA uptake. Injecting oocytes with 1 nmol L-phenylalanine 6 h before uptake studies was not associated with an increase in L-DOPA transport induced by either renal cortical poly-A ϩ or LAT2/4F2 cRNA (Fig. 9 ). L-DOPA uptake by LAT2/4F2 showed simple Michaelis-Menton kinetics with a K m of 6 mM (Fig. 10) . Coinjection of antisense oligonucleotides for LAT2 blocked ϳ30% of poly-A ϩ -induced L-DOPA uptake and ϳ60% of the LAT2 cRNA-induced L-DOPA uptake (Fig. 11 ). This suggests that LAT2 also accounts for some of the L-DOPA transport induced by renal cortical poly-A ϩ . However, there are other low-affinity L-DOPA carriers to be identified.
Because the proximal tubule-like cell line [opossum kidney (OK) cell] also expresses L-DOPA mechanisms, we examined for the contribution of rBAT sequences to this activity on OK cells. Opossum rBAT-specific siRNA sequences from two seperate regions inhibited L-DOPA uptake by ϳ30 -40% compared with OK cells transfected with the vector alone (Fig. 12,   Fig. 4 . L-DOPA uptake induced by renal cortical poly-A ϩ RNA, rBAT, and rBAT/b 0,ϩ AT. X. laevis oocytes were injected with poly-A ϩ RNA from rat kidney cortex or cRNA, and 3 H-L-DOPA uptake was measured by isoptope flux 3-4 days later (left). One typical experiment is shown with each data point representing the means Ϯ SD of 8 -12 oocytes. Three independent studies were performed with similar results. Positive control was done with L-arginine uptake (left). ϩ RNA or rBAT cRNA was annealed to excess rBAT-specific antisense oligonucleotides and injected into oocytes.
3 H-L-DOPA uptake was measured by isoptope flux. Right: control using L-arginine uptake. Fifty micromolar unlabeled L-DOPA and L-arginine were used in this experiment, respectively. One typical experiment is shown with each data point representing the means Ϯ SD of 8 -12 oocytes. Three independent studies were performed with similar results and statistical significance. *Statistical significance (P Ͻ 0.05 ANOVA).
A and B). Knockdown of LAT2 protein was not attempted because of the unavailability of the opossum LAT2 sequence in the database and the fact that the basolateral membane is inaccessible for monolayers on plastic.
DISCUSSION
The data support the conclusion that rBAT and LAT2 are L-DOPA transporters. Accounting for incomplete efficiency of antisense oligonucleotide inhibition, rBAT and LAT2 probably sustain up to ϳ60 -70% of L-DOPA transport in oocytes injected with rat kidney cortex poly-A ϩ mRNA. LAT2 is an amino acid transporter composed of a heavy subunit 4F2hc and a light subunit LAT2 expressed in the basolateral membrane of the proximal tubule allowing exchange of large neutral amino acids (10) . Our data suggest LAT2 is a low-affinity L-DOPA transporter and can possibly account for the basolateral L-DOPA uptake in the proximal tubule cell. rBAT is an amino acid transporter expressed in the apical membrane of the proximal tubule cell and other epithelia composed of a light subunit b 0,ϩ AT and a heavy subunit rBAT involved in the reabsorption of dibasic amino acids like cystine, arginine, and lysine (11) . rBAT could account for the high-affinity apical L-DOPA uptake by proximal tubule cells.
Proximal tubule L-DOPA uptake has often been described as a Na ϩ -dependent process (33), but we showed no siginificant Na ϩ dependence in renal cortical poly-A ϩ -, rBAT-, or LAT2-induced L-DOPA transport. The only study in mammalian perfused tubule actually never examined Na ϩ dependence of L-DOPA flux (4). Most of the older studies assessed L-DOPA uptake by measuring the rate of DA or DOPAC generation or L-DOPA accumulation in kidney cortex slices exposed to varing concentrations of L-DOPA and Na ϩ . The observation of a Na ϩ -induced increase in DA and DOPAC generation can be due to activation of L-DOPA decarboxylation or changes in DA degradation. These studies also showed L-DOPA cellular accumulation even in the absence of Na ϩ , compatible with a Na ϩ -independent mechanism (32). Renal cortical slices harbor Recent studies by Soares-da-Silva and co-workers (34) showed the L-DOPA uptake is Na ϩ independent in LLC-PK 1 cells and mostly Na ϩ independent with a minor Na ϩ -dependent component (ϳ15%) in OK HC cells (10) . Contrary to renal cortical slices, cell culture models reflect the biology of the tubular epithlial cell without contributions of the other cell types. In addition, inhibition of the amino acid transporter systems L (includes LAT1 and LAT2) was associated with a concentration-dependent decrease in L-DOPA uptake in OK cells and L-type amino acids and dibasic amino acids inhibit L-DOPA uptake in OK cells, suggesting the b 0,ϩ -amino acid transport system as a L-DOPA carrier (10) . These findings are congruent with our data on LAT2 and rBAT being Na ϩ -independent L-DOPA carriers accounting for more than 50% of L-DOPA uptake in the proximal tubule. Part of the residual renal cortical poly-A ϩ -induced L-DOPA transport in the background of excess antisense oligonucleotides in oocytes may be due to incomplete inhibition of translation as evidenced by residual activity even with rBAT and LAT2 cRNA. However, the magnitude of inihibition by antisense oligonucleotides is less in poly-A ϩ , suggesting the presence of other L-DOPA transporters. Recent published data described TAT1 to be an L-DOPA carrier in the basolateral membrane (17) . A complete list of proximal tubule L-DOPA carriers remains to be assembled.
Patients with inactivating mutations of rBAT (SLC3A1 gene) have cystine, arginine, and lysine wasting in the urine with the recognizable autosomal recessive clinical phenotype of cystine kidney stones due to the low solubility of cystine (7) . Urinary L-DOPA wasting has never been examined in these patients (6 -8, 23) . Even though basolateral L-DOPA uptake may compensate and prevent defective DA generation, it is conveivable that L-DOPA wasting may go undetected as do the highly soluble arginine and lysine. An indirect finding in humans suggests that L-DOPA and cystine transport may actually compete with one another in the kidney. Dietary salt has been known to exacerbate cystinuria (23) , and salt restriction has been considered as a therapeutic intervention in patients with this disease (15) . Because dietary Na ϩ loading increases L-DOPA uptake by the proximal tubule, it is conceivable that Na ϩ -loading places increased demand on proximal tubule rBAT to transport L-DOPA, leading to a lower capacity for rBAT to reabsorb cystine. This hypothesis remains to be proved or disproved by subsequent experiments planned for the near future by the author of this paper.
Multiple observations suggest that defects in the intrarenal DA system can contribute to both monogenic and polygenic salt-sensitive hypertension (2, 16) . Defective renal DA generation has been described in humans with low-renin hypertension associated with a volume-expanded state. This is hypothesized to be due to defective renal DA generation as evidenced by lower urinary DA and low urinary DA/L-DOPA ratios (6, 19) . The DA/L-DOPA ratio is a surrogate measure of renal DA generation from L-DOPA. Low urinary DA/L-DOPA suggests a defect may reside either in L-DOPA uptake or conversion from L-DOPA to DA. These patients seem to have exaggerated natriuretic responses to exogenous DA compatible with a chronic compensatory response to suboptimal DA generation (26) . These abnomalitites in urinary DA were not present in patients with high-renin hypertension (28) . Of interest is the fact that normotensive relatives of patients with defective renal DA generation have urinary DA and DA/L-DOPA ratios that are intermediate between their hypertensive relatives and normal volunteers. These findings suggest that genes encoding proteins responsible for renal L-DOPA uptake and/or DA generation are candidate genes in the current list of contenders accounting for the development of polygenic hypertension. The identification of L-DOPA carriers permits further studies.
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